Patent · US Revoked

Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

US11066380B2 · kind B2 · utility

0Cited by
62References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2020
Grant dateJul 20, 2021
Priority date
Expiry dateMar 13, 2040

Classification

  • Technology area (CPC —)General

Abstract

The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.